1. From Immune Disease Institute Inc (J.K., A.K.C., I.S.P., D.D.W.) and the Department of Pathology (J.K., A.K.C., D.D.W.), Harvard Medical School, Boston, Mass; Department of Biology (A.Y., M.K.), Massachusetts Institute of Technology, Cambridge, Mass; Medical University of South Carolina (C.N.), Cell and Molecular Pharmacology, Charleston; and Molecular Oncology Research Institute (R.A.V.E.), Tufts–New England Medical Center, Boston, Mass.